Literature DB >> 29354989

[Clinical effect of abdominal acupuncture for diarrhea irritable bowel syndrome].

Yu Qin1, Wei Yi1, Shuxiong Lin1, Chunfang Yang1, Zemin Zhuang1.   

Abstract

OBJECTIVE: To compare the efficacy differences between abdominal acupuncture and western medication for diarrhea irritable bowel syndrome (IBS-D).
METHODS: Sixty-one patients with IBS-D were randomly assigned into an acupuncture group (30 cases after 1 dropping) and a western medication group (28 cases after 2 dropping). Acupuncture was used at Yinqiguiyuan points [Zhongwan (CV 12), Xiawan (CV 10), Qihai (CV 6), Guanyuan (CV 4)], Fusiguan points [bilateral Huaroumen (ST 24), Wailing (ST 26)], Tiaopiqi point [bilateral Daheng (SP 15)], once every other day, 3 times a week. Pinaverium bromide tablet was used orally in the western medication group, 50 mg a time, 3 times a day. All the treatment was given for 4 weeks in the two groups. IBS symptom severity score (IBS-SSS) and clinical symptom scores for abdominal pain and distension, diarrhea, poor stool output, defecation urgency and stool abnormality were observed before and after the treatment as well as 3 months after treatment. Adverse reactions were recorded and the effects were evaluated.
RESULTS: ①After treatment and at follow-up, the IBS-SSS scores of the two groups were lower than those before treatment (all P<0.01). Compared with the western medication group, the scores and the improvements between the two time points and before treatment were better in the acupuncture group (P<0.05, P<0.01). ②The symptom scores in the two groups after treatment were lower than those before treatment including abdominal pain, abdominal distension, diarrhea, poor stool output, defecation urgency and stool abnormality (P<0.05, P<0.01), and the scores of abdominal pain, abdominal distension, diarrhea, poor stool output and stool abnormality in the acupuncture group were lower than those in the western medication group (P<0.05, P<0.01). ③The total effective rate and the cured and remarkable effective rate of the acupuncture group were higher than those of the western medication group [(86.7% (26/30) vs 64.3% (18/28), P<0.05; 70.0% (21/30) vs 35.7% (10/28), P<0.01)], and the therapeutic efficacy of the acupuncture group was better than that of the western medication group (P<0.05). There was no adverse reaction.
CONCLUSION: Abdominal acupuncture is more effective for IBS-D than western medication and can relieve abdominal pain, abdominal distension, diarrhea, poor stool output, stool abnormality, with long-term effect.

Entities:  

Keywords:  abdominal acupuncture; diarrhea; irritable bowel syndrome; pinaverium bromide

Mesh:

Substances:

Year:  2017        PMID: 29354989     DOI: 10.13703/j.0255-2930.2017.12.003

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  5 in total

1.  Brain Functional Interaction of Acupuncture Effects in Diarrhea-Dominant Irritable Bowel Syndrome.

Authors:  Kai Ma; Yongkang Liu; Wei Shao; Jianhua Sun; Jing Li; Xiaokun Fang; Jing Li; Zhongqiu Wang; Daoqiang Zhang
Journal:  Front Neurosci       Date:  2020-12-15       Impact factor: 4.677

2.  A Meta-Analysis of the Effect of Abdominal Acupuncture on Post-Stroke Depression.

Authors:  Irene J Su; Lili Liao; Fuhua Huang
Journal:  Med Acupunct       Date:  2021-08-17

3.  Acupuncture for functional gastrointestinal disorders: A systematic review and meta-analysis.

Authors:  Xi-Yang Wang; Hao Wang; Yuan-Yuan Guan; Rong-Lin Cai; Guo-Ming Shen
Journal:  J Gastroenterol Hepatol       Date:  2021-08-18       Impact factor: 4.369

Review 4.  Comparison between the Effects of Acupuncture Relative to Other Controls on Irritable Bowel Syndrome: A Meta-Analysis.

Authors:  Haizhen Zheng; Rixin Chen; Xiaofeng Zhao; Guanhui Li; Yi Liang; Hao Zhang; Zhenhai Chi
Journal:  Pain Res Manag       Date:  2019-11-11       Impact factor: 3.037

Review 5.  Efficacy of Acupuncture in the Treatment of Chronic Abdominal Pain.

Authors:  Amnon A Berger; Yao Liu; Kevin Jin; Alicia Kaneb; Alexandra Welschmeyer; Elyse M Cornett; Alan David Kaye; Farnad Imani; Seyed-Hosein Khademi; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Anesth Pain Med       Date:  2021-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.